Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Weever rhabdovirus recombinant G2 protein and application thereof

A rhabdovirus and protein technology, applied in the field of perch rhabdovirus recombinant G2 protein, can solve the problems of restriction, difficult to meet the requirements of large-scale industrialization, enzymatic inactivation, etc., and achieve good protection and good immunogenicity. and immune protective properties, the effect of good protective efficacy

Active Publication Date: 2021-10-19
深圳万可森生物科技有限公司
View PDF6 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, injection immunization has the best protective effect, but it is difficult to meet the requirements of large-scale industrialization due to operating technology and production costs; although immersion and oral immunization are simple in operation technology and low in production cost, there are also defects in the body surface skin and intestines. A series of insurmountable technical problems such as barrier restriction, enzymatic inactivation, and low immune protection rate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Weever rhabdovirus recombinant G2 protein and application thereof
  • Weever rhabdovirus recombinant G2 protein and application thereof
  • Weever rhabdovirus recombinant G2 protein and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Embodiment 1: Recombinant Escherichia coli E. coli Construction and identification of BL21 / pET32a-G2 strain

[0034] G2 target gene amplification

[0035] Referring to the instructions of the viral RNA extraction kit, the MSRV FJ985 strain virus liquid cultured with CO cells (the MSRVFJ985 strain was provided by Northwest A&F University, see Fei Yang et al. Evaluation on the antiviral activity of ribavirin against Micropterus salmoides rhabdovirus (MSRV) in in vitro and in vivo , Aquaculture, Volume 543 , Internet release time: May 27, 2021) as materials to extract MSRV virus RNA. Agarose gel electrophoresis was used to detect the integrity of the RNA, and a micro-nucleic acid analyzer was used to determine the concentration and quality of the sample RNA. The extracted RNA samples were reversed into cDNA using a reverse transcription kit.

[0036] After a large number of designs, the G2 fragment with the amino acid sequence of SEQ ID No: 2 was selected, and ...

Embodiment 2

[0053] Example 2: Evaluation of immune efficacy of recombinant protein

[0054] During the research and development process, different fragments were designed, and different glycoprotein fragments and complete glycoproteins were prepared using the method of Example 1, glycoprotein fragment G1 (amino acid sequence is SEQ ID No: 3), glycoprotein fragment G3 (The amino acid sequence is SEQ ID No: 4) protein and the complete glycoprotein (the amino acid sequence is SEQ ID No: 5), respectively verifying the immune efficacy of the above protein fragments. Specifically, the following immune efficacy evaluation test was adopted: 300 healthy perch were randomly divided into 6 groups, including the control group (PBS), the G1 protein group (40 mg / L), the G2 protein group (40 mg / L), and the G3 protein group. (40 mg / L), G protein group (40 mg / L), G protein group (80 mg / L), all sea bass were vaccinated with the corresponding vaccines through the bath solution and soaked for 6 hours. Subse...

Embodiment 3

[0056] Embodiment 3: the preparation of subunit vaccine

[0057] Functional modification of single-walled carbon nanotubes

[0058] The structure modification of single-walled carbon nanotubes is carried out by the mixed acid oxidation method, and the steps are as follows:

[0059] (1) Put 2g single-walled carbon nanotube sample into 150mL concentrated H 2 SO 4 and 50mL concentrated HNO 3 placed in a magnetic stirrer at 100 rpm for 48 h at room temperature;

[0060] (2) Filter the mixed acid mixture of carbon nanotubes obtained in the previous step with a circulating water vacuum pump, wash with pure water until the pH of the liquid is 7.4, then dry it at 60°C, and grind it into powder in a mortar , through a 300-mesh sieve, and the resulting product is functionalized single-walled carbon nanotubes (o-SWCNTs).

[0061] Preparation of carbon nanotube carrier subunit vaccine

[0062] Take the acidified single-walled carbon nanotube sample (0.5g) and add it to 2-(N-morpholi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

G2 protein is obtained through prokaryotic recombinant expression, the protein fragment has good immunogenicity, can stimulate an organism to generate a high antibody level, and has better immunogenicity and immune protection performance compared with the whole G protein and other fragments; a carbon nano tube carrier sub-unit vaccine prepared on the basis of combination of a G2 protein and a functional carbon nano tube attacks an MSRV FJ985 strain 21 days after immunizing weever, the immune protection rate of the weever is 86% and is higher than the protection rate reported in the prior art, on the basis of selection of specific protein fragments, and compared with the original G protein and other G protein fragments obtained based on immunoassay, the G protein fragment has better protective efficacy, can generate a better protective effect after immunizing weever, and can enable the weever to effectively resist attack of MSRV virulent virus.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a perch rhabdovirus recombinant G2 protein and application thereof. Background technique [0002] by perch rhabdovirus ( Micropterus salmoides rhabdovirus, MSRV ) caused the most serious damage to perch rhabdovirus disease, which has a wide range of prevalence, a long onset time, and a mortality rate of more than 85%, which has brought huge economic losses to perch farming. MSRV is a single-stranded RNA virus with a size of (100-430) nm × (45-100) nm and a rod-like or bullet-like shape. The MSRV genome mainly encodes five structural proteins, namely nucleoprotein N, phosphoprotein P, mitrix M, glycoprotein G, and RNA polymerase L. [0003] G protein is glycoprotein, which is mainly responsible for binding to host cell receptors and is the main antigenic protein of viruses. According to the deduced amino acid sequence, it is speculated that the G protein is similar to o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/145C12N15/47C12N15/70A61K38/16A61P31/14
CPCC07K14/005C12N15/70A61P31/14C12N2760/20022A61K38/00
Inventor 王高学朱斌凌飞郭孜饶焦铁军
Owner 深圳万可森生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com